2seventy bio Inc (TSVT)
5.00
+0.05
(+1.01%)
USD |
NASDAQ |
May 07, 14:10
2seventy bio Cash from Investing (Quarterly): 47.89M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.89M |
| September 30, 2023 | 16.05M |
| June 30, 2023 | -64.88M |
| March 31, 2023 | 44.80M |
| December 31, 2022 | -8.50M |
| September 30, 2022 | -82.30M |
| Date | Value |
|---|---|
| June 30, 2022 | 49.80M |
| March 31, 2022 | 44.75M |
| December 31, 2021 | 1.014M |
| September 30, 2021 | -8.624M |
| June 30, 2021 | -3.625M |
| March 31, 2021 | -6.351M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-82.30M
Minimum
Sep 2022
49.80M
Maximum
Jun 2022
2.502M
Average
-1.306M
Median
Cash from Investing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -19.62B |
| Johnson & Johnson | -464.00M |
| Macrogenics Inc | 38.82M |
| Akebia Therapeutics Inc | 0.00 |
| Tango Therapeutics Inc | 33.85M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -63.60M |
| Cash from Financing (Quarterly) | 0.253M |
| Free Cash Flow | -180.72M |
| Free Cash Flow Per Share (Quarterly) | -1.258 |
| Free Cash Flow to Equity (Quarterly) | -64.67M |
| Free Cash Flow to Firm (Quarterly) | -64.67M |
| Free Cash Flow Yield | -73.38% |